Condition: Chronic Low-back Pain · Herniated Disc · Degenerative Disc Disease · Sponsor: BACKBONE
The study is a post-market surveillance study of the Lumbar Implant for Stiffness Augmentation (LISA), a medical device, which is used to treat low-back pain that accompanies degenerative lesions of grades II, III, and IV (Pfirrmann MRI classification). "Post-market" means the device (i.e. the LISA implant) being used in this study has already obtained CE certification and is commercially available for use in the European market. The LISA device consists of 3 components: A PEEK interspinous spacer, a polyester band, and a titanium blocker. The spacer is positioned between two adjacent spinous processes, the band is belted around the spinous processes and through the spacer, and the blocker is used to lock the band inside the spacer. Medical Device manufacturers conduct "post-market" clinical studies in order to continuously evaluate the product scientifically and to comply with legal and ethical obligations. With these studies, the long-term safety as well as performance of their medical devices are assessed. This study, which is initiated and sponsored by BACKBONE (LISA designer, developer, manufacturer and marketer), aims to evaluate the long-term safety and performance of the LISA implant for the treatment of lumbar degenerative disease and to evaluate the treatment.
This description comes directly from the study's public registry record.
Aurélie Affret · 0033686114973 · aat@backbone.pro
Nazanine Sahami · 0033646592539 · nsi@backbone.pro
Always discuss trial participation with your own doctor first.
| Elective Surgery Center, Silkeborg Regional Hospital | Silkeborg, Denmark | Recruiting |
| Pellegrin University Hospital Center | Bordeaux, France | Recruiting |
| Saint-Charles Clinic | Lyon, France | Recruiting |
| Pitié-Salpêtrière University Hospital Center | Paris, France | Recruiting |
| Asklepios Stadtklinik, Bad Wildungen | Bad Wildungen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04631133